Page last updated: 2024-11-07

methacetin and Hepatocellular Carcinoma

methacetin has been researched along with Hepatocellular Carcinoma in 5 studies

methacetin: RN given refers to parent cpd
methacetin : A member of the class of acetamides that is paracetamol in which the hydrogen of phenolic hydroxy group has been replaced by a methyl group.

Research Excerpts

ExcerptRelevanceReference
"Methacetin metabolism was significantly decreased following TACE (-28%, P < 0."2.74Liver function as assessed by breath tests in patients with hepatocellular carcinoma. ( Grattagliano, I; Minerva, F; Palasciano, G; Palmieri, VO; Pollice, S; Portincasa, P, 2009)
"Thirty-nine patients with primary liver cancer, 16 patients with hepatic metastasis and 14 healthy volunteers serving as controls were included in this study."2.74[The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test]. ( Feng, QL; Li, HX; Wang, JP; Yang, Y; Zhang, J, 2009)
"20 patients with intermediate-stage hepatocellular carcinoma (HCC) received a LiMAx test 24 h pre and post TACE."1.62Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test. ( Bäumler, W; Haimerl, M; Rio Bartulos, C; Senk, K; Stroszczynski, C; Verloh, N; Wiggermann, P; Wilcke, J, 2021)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Senk, K1
Wilcke, J1
Haimerl, M1
Verloh, N1
Rio Bartulos, C1
Bäumler, W1
Stroszczynski, C1
Wiggermann, P1
Gairing, SJ1
Kuchen, R1
Müller, L1
Cankaya, A1
Weerts, J1
Kapucu, A1
Sachse, S1
Zimpel, C1
Stoehr, F1
Pitton, MB1
Mittler, J1
Straub, BK1
Marquardt, JU1
Schattenberg, JM1
Labenz, C1
Kloeckner, R1
Weinmann, A1
Galle, PR1
Wörns, MA1
Foerster, F1
Palmieri, VO1
Grattagliano, I1
Minerva, F1
Pollice, S1
Palasciano, G1
Portincasa, P1
Li, HX1
Wang, JP1
Yang, Y1
Zhang, J1
Feng, QL1
Matsumoto, K1
Suehiro, M1
Iio, M1
Kawabe, T1
Shiratori, Y1
Okano, K1
Sugimoto, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569]Phase 3120 participants (Anticipated)Interventional2005-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for methacetin and Hepatocellular Carcinoma

ArticleYear
Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    The Journal of surgical research, 2009, Volume: 157, Issue:2

    Topics: Acetamides; Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular

2009
[The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test].
    Zhonghua nei ke za zhi, 2009, Volume: 48, Issue:5

    Topics: Acetamides; Aged; Aged, 80 and over; Breath Tests; Carcinoma, Hepatocellular; Case-Control Studies;

2009

Other Studies

3 other studies available for methacetin and Hepatocellular Carcinoma

ArticleYear
Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test.
    Clinical hemorheology and microcirculation, 2021, Volume: 79, Issue:1

    Topics: Acetamides; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic

2021
13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Clinical and translational gastroenterology, 2022, 10-01, Volume: 13, Issue:10

    Topics: Albumins; Bilirubin; Breath Tests; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; End St

2022
[13C]methacetin breath test for evaluation of liver damage.
    Digestive diseases and sciences, 1987, Volume: 32, Issue:4

    Topics: Acetamides; Adult; Breath Tests; Carbon Dioxide; Carcinoma, Hepatocellular; Female; Humans; Liver Ci

1987